🔬
You have used your free lookups for today
Upgrade to BiotechSigns Pro for unlimited company access, full signal history, watchlist alerts, and 125+ PDUFA dates.
Upgrade to Pro →← Back to screener
← Back to Screener
S

SPRY

Spruce Biosciences
EndocrinologyScore: 39/100📋 Full Profile
D
39

What is the current SPRY catalyst setup?

SPRY is tracked by BiotechSigns with a current catalyst score of 39/100 and grade D. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.

Analyst Summary
Verified 2026-04-11

Spruce Biosciences (SPRY) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

No Form 4 insider filings for SPRY were recorded at the SEC in the past 30 days[1].

Sources

  1. SEC EDGAR · 0001671858 (2026-04-11)
Not financial advice. BiotechSigns scores are for informational purposes only and do not constitute investment recommendations. Always do your own due diligence before making investment decisions.
No active signals for SPRY
Signal Summary
PDUFA0
Insider0
Clinical0
Data Sources
Dilution◌ LOADING
Sentiment◌ LOADING
SEC EDGAR● LIVE
ClinicalTrials● LIVE
Yahoo Finance● LIVE